The Latest Headlines at Daily Political


Hims & Hers Health, Inc. (NYSE:HIMS) Given Average Recommendation of “Hold” by Analysts
Hims & Hers Health, Inc. (NYSE:HIMS – Get Rating) has earned a consensus rating of “Hold” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research... More of this article »
Financial Comparison: Grom Social Enterprises (NASDAQ:GROM) versus Sportradar Group (NASDAQ:SRAD)
Sportradar Group (NASDAQ:SRAD – Get Rating) and Grom Social Enterprises (NASDAQ:GROM – Get Rating) are both consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on... More of this article »
Insider Selling: AmerisourceBergen Co. (NYSE:ABC) CEO Sells $1,655,990.00 in Stock
AmerisourceBergen Co. (NYSE:ABC – Get Rating) CEO Steven H. Collis sold 11,480 shares of the stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $144.25, for a total transaction of $1,655,990.00.... More of this article »Analyzing TechTarget (NASDAQ:TTGT) & Pinduoduo (NASDAQ:PDD)
TechTarget (NASDAQ:TTGT – Get Rating) and Pinduoduo (NASDAQ:PDD – Get Rating) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their... More of this article »
Biotricity (BTCY) vs. Its Competitors Head to Head Review
Biotricity (OTCMKTS:BTCY – Get Rating) is one of 85 publicly-traded companies in the “Electric services” industry, but how does it compare to its peers? We will compare Biotricity to similar companies based on the... More of this article »
Critical Survey: Mawson Infrastructure Group (NASDAQ:MIGI) vs. Shutterstock (NYSE:SSTK)
Mawson Infrastructure Group (NASDAQ:MIGI – Get Rating) and Shutterstock (NYSE:SSTK – Get Rating) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based... More of this article »
Algoma Steel Group (ASTL) versus Its Competitors Head-To-Head Contrast
Algoma Steel Group (NASDAQ:ASTL – Get Rating) is one of 27 public companies in the “Blast furnaces & steel mills” industry, but how does it compare to its competitors? We will compare Algoma Steel Group to related... More of this article »
Head-To-Head Review: Local Bounti (NYSE:LOCL) versus Verano (OTCMKTS:VRNOF)
Local Bounti (NYSE:LOCL – Get Rating) and Verano (OTCMKTS:VRNOF – Get Rating) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their... More of this article »
Insider Selling: Karuna Therapeutics, Inc. (NASDAQ:KRTX) Insider Sells $5,702,000.00 in Stock
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) insider Stephen K. Brannan sold 25,000 shares of the firm’s stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $228.08, for a... More of this article »
National Bankshares Raises Hydro One (TSE:H) Price Target to C$36.00
Hydro One (TSE:H – Get Rating) had its target price upped by National Bankshares from C$34.00 to C$36.00 in a research note published on Wednesday morning, BayStreet.CA reports. The firm currently has a sector perform rating... More of this article »
Skandinaviska Enskilda Banken AB (publ) (OTCMKTS:SVKEF) vs. VersaBank (NASDAQ:VBNK) Financial Review
Skandinaviska Enskilda Banken AB (publ) (OTCMKTS:SVKEF – Get Rating) and VersaBank (NASDAQ:VBNK – Get Rating) are both finance companies, but which is the superior investment? We will compare the two businesses based on... More of this article »
Blue Ridge Real Estate (OTCMKTS:BRRE) & Alset EHome International (NASDAQ:AEI) Critical Comparison
Blue Ridge Real Estate (OTCMKTS:BRRE – Get Rating) and Alset EHome International (NASDAQ:AEI – Get Rating) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based... More of this article »
Morgan Stanley Lowers REGENXBIO (NASDAQ:RGNX) Price Target to $46.00
REGENXBIO (NASDAQ:RGNX – Get Rating) had its price objective cut by Morgan Stanley from $47.00 to $46.00 in a report issued on Wednesday morning, MarketBeat Ratings reports. They currently have an overweight rating on the biotechnology... More of this article »